Scout Investments’s Zimmer Biomet ZBH Stock Holding History

Scout Investments’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-483,474	Closed	-$44.4M	–	298
2014 Q1	$44.4M	Sell	483,474 -32,865	-6%	-$3.03M	0.51%	67
2013 Q4	$46.7M	Buy	516,339 +8,205	+2%	+$710K	0.54%	60
2013 Q3	$40.5M	Buy	508,134 +221,048	+77%	+$17.4M	0.28%	122
2013 Q2	$20.9M	Buy	+287,086	New	+$21.5M	0.24%	114

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

IIS

Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Scout Investments's ZBH Position: Q2 2014 in Review

Scout Investments sold out of Zimmer Biomet (ZBH) in Q2 2014, closing a stake of 483,474 shares — an estimated $44.4M sold.

Scout Investments first reported a position in ZBH in Q2 2013 and held it in 4 quarters. The position peaked at $46.7M in Q4 2013. 707 funds tracked by Wall St. Rank hold ZBH as of Q2 2014.

Scout Investments reported no remaining Zimmer Biomet position as of Q2 2014 after selling out during the quarter.
Scout Investments sold 483,474 Zimmer Biomet shares in Q2 2014, an estimated $44.4M.
Scout Investments first reported a position in Zimmer Biomet in Q2 2013 and held it in 4 quarters.
Scout Investments's Zimmer Biomet position peaked at $46.7M in Q4 2013.
707 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2014.

Based on Scout Investments's 13F filing for Q2 2014, filed 4 Aug 2014.